3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
20
Carcinoma, Non-Small-Cell Lung
19
Pancreatic Neoplasms
17
Triple Negative Breast Neoplasms
16
Neoplasm Metastasis
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Neoplasms
5
Lung Neoplasms
4
Carcinoma
4
Neoplasms by Site
3
Adenocarcinoma
3
Pancreatic Diseases
2
Ovarian Neoplasms
2
Neoplasms by Histologic Type
2
Fallopian Tube Neoplasms
2
Endocrine System Diseases
2
Endocrine Gland Neoplasms
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Ductal, Breast
2
Vaccinia
1
Thromboembolism
1
Thoracic Neoplasms
1
Squamous Non-Small Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Peritoneal Neoplasms
1
Pancreatic cancer, adult
1
Interventions
pamrevlumab
1
folfirinox
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pancreatic Cancer Non-resectable
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT03941093
2024-11-05
LAPIS
Kyntra Bio
Phase 3
Completed
284 enrolled
14 charts